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The aim of the present study was to find out whether the incorporation of organic dairy and meat products in the maternal diet affects the contents
of the conjugated linoleic acid isomers (CLA) and trans-vaccenic acid (TVA) in human breast milk. To this purpose, milk samples from 312
breastfeeding mothers participating in the KOALA Birth Cohort Study have been analysed. The participants had documented varying lifestyles
in relation to the use of conventional or organic products. Breast milk samples were collected 1 month postpartum and analysed for fatty acid
composition. The content of rumenic acid (the main CLA) increased in a statistically significant way while going from a conventional diet (no
organic dairy/meat products, 0·25 weight % (wt%), n 186) to a moderately organic diet (50–90 % organic dairy/meat, 0·29 wt%, n 33,
P¼0·02) and to a strict organic diet (.90 % organic dairy/meat, 0·34 wt%, n 37, P#0·001). The levels of TVA were augmented among the par-
ticipants with a moderately organic diet (0·54 wt%) and those with a strict organic diet (0·59 wt%, P#0·001), in comparison with the conventional
group (0·48 wt%). After adjusting for covariables (recruitment group, maternal age, maternal education, use of supplements and season), statistical
significance was retained in the group of the strict organic dairy users (P,0·001 for rumenic acid). Hence, the levels of CLA and TVA in human
milk can be modulated if breastfeeding mothers replace conventional dairy and/or meat products by organic ones. A potential contribution of CLA
and TVA to health improvement is briefly discussed.
Conjugated linoleic acid: trans-Vaccenic acid: Human milk: Organic nutrition
The term conjugated linoleic acid (CLA) describes a mixture
of positional and geometric isomers of linoleic acid
(C18 : 2n-6) which contain a conjugated double-bond system
instead of the more common isolated double bonds (for a
very recent review see Bhattacharya et al. 2006). Rumenic
or cis-9,trans-11-octadecadienoic acid (cis9,trans11-C18 : 2)
is the most common CLA isomer and is often regarded as
the biologically most relevant one (Fritsche & Steinhart,
1998). The various CLA are produced in the rumen of rumi-
nant animals mainly by the bacteria Butyrivibrio fibrisolvens
(Kepler et al. 1966; Kim et al. 2000) through reactions of iso-
merization and biohydrogenation. These reactions lead as well
to the formation of a wide variety of trans- and cis-monoenic
fatty acids (especially C18 : 1 trans isomers). In addition,
trans-vaccenic acid (trans11-C18 : 1, TVA) which originates
from linoleic and linolenic acid plays an important role as pre-
cursor of rumenic acid. Very recent work has shown that the
conversion of TVA in rumenic acid does occur as well in
man (Mosley et al. 2006). CLA are currently receiving
much attention in nutritional research, since there is exper-
imental evidence suggesting that these fatty acids might
have anti-carcinogenic, anti-atherosclerotic, anti-diabetic and
immune-modulating effects, as well as a favourable influence
on body fat composition, i.e. on the proportion of fat tissue to
muscle mass (Belury, 2002). Most of this experimental evi-
dence derives from in vitro experiments or animal tests (Bhat-
tacharya et al. 2006), which justifies the recent interest in
clinical trials concerning the relevance of CLA for human
health. The newly published reports concerning the effect
of CLA supplementation on health-related outcomes have
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contradicting messages and in some cases an isomer-specific
effect on the lipid profile could be shown (for a review
see Tricon et al. 2005). A double-blind study revealed
that the consumption of dairy products naturally enriched in
cis9,trans11-C18 : 2 increases the level of this fatty acid in
plasma and cellular lipids (Burdge et al. 2005). However,
this change did not appear to have a significant effect on the
whole blood lipid profile, including several CVD risk par-
ameters (Tricon et al. 2006).
It is known that the lipid composition of cow’s milk is
strongly influenced by the stable conditions and feeding man-
agement, with milk from cows held in organic farms
(Germany, Italy) containing significantly more CLA than
that from their conventionally held counterparts (Jahreis
et al. 1997; Bergamo et al. 2003). Note that farms certified
as ‘organic’ are those in which the use of synthetic inputs,
such as synthetic fertilizers and pesticides, preventive veterin-
ary drugs, genetically modified seeds and breeds, most preser-
vatives, additives and irradiation are excluded (htpp://
www.ifoam.org/sub/faq.html). Since the major source of
CLA in man is the diet, we have hypothesized that the
amount of CLA in the milk of breastfeeding women could
be augmented by increasing the amount of organic dairy nutri-
ents within their diet. The sources of CLA for man comprise
not only dairy products but also ruminant meat (Ritzenthaler
et al. 2001); therefore, emphasis was put on these two
groups of nutrients. In a small pilot study in Switzerland, we
have previously found that the milk from breastfeeding
women who obtained more than 50 % of the energy content
of their diet from organic products had about 30 % higher
CLA content at 4 and 40 days post-partum, compared to con-
trols consuming the same mixture (dairy products and meat) of
conventional products (Rist et al. 2003). The aim of the
KOALA Birth Cohort Study, which is being performed in
the Netherlands, is to identify factors that influence the clinical
expression of atopic disease with a main focus on lifestyle
including, among other parameters, dietary habits, breastfeed-
ing and breast milk composition (Kummeling et al. 2005).
Accordingly, this cohort study comprised persons with alterna-
tive lifestyles, including organic food choice, which offered an
opportunity to study the effect of organic food intake on the
lipid composition of breast milk and, in particular, on the cor-
responding CLA content.
In summary, we addressed the question whether an organic
diet of the mothers can result in increased levels of CLA and
TVA in human milk. Accordingly, the relative amounts of
these fatty acids were measured in the milk from 312 breast-
feeding women following diets with different content of
organic dairy and/or meat products. While about 50 % of the
study participants consumed conventional food, the remaining
women included organic dairy and meat products in their diet.
The present results, showing that an organic diet can lead to
increased levels of CLA and TVA, are discussed in view of
the possible health-favourable properties of these fatty acids.
Subjects and methods
Subjects and collection of breast milk
Breast milk samples were donated by breastfeeding partici-
pants to the KOALA study, a prospective birth cohort study
described in detail elsewhere (Kummeling et al. 2005).
Briefly, we recruited participants with varying lifestyles (con-
ventional and alternative). Pregnant women with a conven-
tional lifestyle (n 2343) were recruited from an ongoing
prospective cohort study on Pregnancy-related Pelvic Girdle
pain in the Netherlands (Bastiaanssen et al. 2005). During
the same recruitment period (December 2002 to August
2003), pregnant women with an alternative lifestyle, which
included the use of organic food (n 491), were recruited
through several channels, such as organic food shops, anthro-
posophic clinicians and midwives, Rudolf Steiner schools and
relevant magazines. Finally, 312 (146 from the conventional
and 166 from the alternative recruitment group) were enrolled,
each donating one sample of breast milk, 1 month post-
partum. The study was approved by the Medical Ethical
Committee of Maastricht University/Academic Hospital
Maastricht, Maastricht, The Netherlands.
Breast milk sampling and extraction of total milk lipids
Mothers received a sterile 50 ml tube (Cellstar PP-test tubes;
Greiner Bio-One, Kremsmuenster, Austria) and were
instructed to collect the milk sample in the morning, before
breastfeeding their child, from the contra-lateral breast
(since the last feeding) and to keep the tube in the refrigerator
(at approximately 48C) until it was collected by one of the
researchers. If the mother was not able to collect the milk
sample by herself (with or without a pumping regimen), an
electric breast pump (Medela, Baar, Switzerland) was used
with the help of one of the researchers, within the same day.
Collection and processing of the breast milk samples occurred
on the same day. During transport the milk samples were
stored in a cooler (Coleman Company, Inc., Breda, The
Netherlands) on packed ice (at approximately 48C). Fractions
for fatty acids analysis were preserved by mixing approximately
2 ml milk with 2ml butylated hydroxytoluene–methanol
(1 : 1, v/v). The samples were stored at 280 8C in plastic sto-
rage vials (Sarstedt, Nu¨mbrecht, Germany) at the European
Biobank in Maastricht (the Netherlands), until analysis.
Lipids were extracted from the 0·2 ml milk samples with
3 ml chloroform–methanol (2 : 1, v/v containing 0·001 % buty-
lated hydroxytoluene) after adding water to improve phase
separation and 200ml of the internal standard (containing
approximately 200mg heptadecenoic acid methyl ester in
n-hexane, cis10-C17 : 1). The lower organic phase was trans-
ferred into a Pyrex glass tube and extraction was repeated
twice. The combined organic phases were evaporated to dry-
ness under a nitrogen stream at 408C.
Fatty acid analysis
The lipid extracts were transmethylated with 5 % potassium meth-
ylate solution in methanol for 30 min at 608C. After cooling to
room temperature, 3 ml 0·5 M-methanolic sulphuric acid in metha-
nol were added. Thereafter, the extracts were vortexed and heated
at 608C for 15 min. After cooling, 3 ml saturated sodium chloride
solution in water and 2 ml n-hexane phase were added. The newly
formed fatty acid methyl esters were then extracted into the
n-hexane phase by vortexing. The upper n-hexane phase was
transferred after centrifugation into a 4 ml glass vial; the extrac-
tion was repeated once. The combined n-hexane phases were
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evaporated to dryness under a stream of nitrogen and solved in
500ml n-hexane. Fatty acid methyl esters were analysed by
GC–free induction decay (GC–FID) and Agþ–HPLC essen-
tially as previously described (Mu¨ller et al. 2005). For the GC–
FID analysis, an Agilent 6890 GC (Agilent Technologies, Wald-
broon, Germany) equipped with a split/splitless injector at 2308C,
a flame ionization detector at 2608C, an autosampler and a CP SIL
88 column (100 m, 0·25 mm, 0·2mm film thickness; Varian,
Darmstadt, Germany) was used. Hydrogen was used as carrier,
at a constant flow rate of 1 ml/min. The temperature of the GC
oven was set to 708C for 3 min, increased at 88C/min up to
1808C, held for 2 min, increased at 48C/min up to 2108C, held
for 4 min, increased at 28C/min to a final temperature of 2408C
and held for 25 min. The data were analysed using the HP Chem-
station software (Rev. A08.03); the percentage method which
excludes the internal standard was used, to allow a better compari-
son of the fatty acids among the various samples. Conjugated fatty
acid isomers were separated using Ag þ –HPLC– diode-array
detection. The system consisted of an isocratic Merck-Hitachi
L-6000 A HPLC pump equipped with a Waters 717 autosampler
(Waters, Eschborn, Germany) and a Waters 996 diode-array
detector operated at wavelength between 210·4 and 395·4 nm.
Three Chromspher 5 lipid columns (250 mm £ 4·6 mm, 5mm)
were used in series with a 50 mm £ 4·6 mm pre-column of the
same column material (Varian). Propionitrile at 0·02 % in
n-hexane was used as eluent at a flow rate of 1 ml/min (approxi-
mately 80 bar). Millennium32 software (Version 3.20; Waters)
was used for data analysis. The following CLA isomers were con-
sidered in the analysis: trans12,trans14-, trans11,trans13-,
trans10,trans12-, trans9,trans11-, trans8,trans10-, trans7,-
trans9-, cis11,trans13-, trans10,cis12-, cis11,trans13-, trans11,-
cis13-, cis9,trans11-, trans8,cis10-, cis11,cis13-, cis10,cis12-,
cis9,cis11- and cis8,cis10-C18 : 2.
FFQ
The FFQ (Kummeling et al. 2005) was included in a self-
administered questionnaire in week 34 of the pregnancy.
The questionnaire was based on an existing validated one
(Grootenhuis et al. 1995), which was extended and modified
to meet the specific aims of the present study. To make the
questionnaire suitable for subjects with a vegetarian, anthropo-
sophic, macrobiotic or other alternative dietary lifestyle,
specific foods often used by these groups were included as
well. The FFQ consisted of approximately 160 food items,
for which the frequency of consumption and portion size
were to be estimated. Furthermore, we have asked for infor-
mation concerning the origin of the various food groups, for
each of the three following food categories: dairy products,
meat and certain other food items. The study participants
had to specify whether the aliments had originated from con-
ventional, organic or biodynamic – a special form of organic
agriculture in which emphasis is put on activating the life of
the soil by using natural preparations from plant and animal
origin – production. The patients who consumed organic
(including biodynamic) food were asked whether these consti-
tuted ,50 %, 50–90 % or .90 % of the food, within the
corresponding food group. Since biodynamic foods are
expensive, difficult to find and often used as an adjunct to
organic foods, we only asked whether subjects used ‘any’
foods of biodynamic origin, again distinguishing between
dairy products, meat and other food groups.
Subjects were classified into four groups distinguished
in terms of the origin of the meat and dairy products:
(1) conventional (if ,50 % of both the meat and dairy they
used was of organic origin, or they ate no meat and ,50 %
of the dairy they used was of organic origin, or they ate no
dairy and ,50 % of the meat they used was of organic
origin); (2) 50–90 % organic (if .50 % of both the meat
and dairy they used was of organic origin but ,90 % of one
of the two was of organic origin, or they ate no meat and
50–90 % of the dairy they used was of organic origin, or
they ate no dairy and 50–90 % of the meat they used was
of organic origin); (3) .90 % organic (if .90 % of both the
meat and dairy they used was of organic origin, or they ate
no meat and .90 % of the dairy they used was of organic
origin, or they ate no dairy and .90 % of the meat they
used was of organic origin); (4) other (including any combi-
nation of ,50 % meat of organic origin and .50 % dairy of
organic origin or vice versa, and missing and inconsistent
data). For the purpose of the present study, only those food
items which are relevant dietary sources of CLA were docu-
mented: milk and milk products, including cheese and butter
(nineteen food items), meat and meat products (nineteen
food items). Fat intake from these food groups was calculated
using the most recent Dutch Food Composition Table (Anon-
ymous, 2001). Calculation of fat intake from meat was limited
to that of ruminant cattle such as beef and veal (omitting
minced and processed meat because it is often a mixture of
beef and pork), lamb and mutton; throughout this paper, we
refer to these nutrients as ‘meat’ only, for simplicity reasons.
Since we expected that the fatty acid composition of the breast
milk could be influenced by the use of dietary supplements
during pregnancy and lactation, the questionnaire adminis-
tered during the pregnancy and a questionnaire administered
at the moment of breast milk sampling included detailed ques-
tions on the use of supplements with borage oil or primrose oil
(both containing g-linolenic acid, C18 : 3n-6) and fish oil (con-
taining eicosapentaenoic acid, C20 : 5n-3; docosapentaenoic
acid, C22 : 5n-3; docosahexaenoic acid, C22 : 6n-3).
Statistical methods
Duplicate values of fatty acids – expressed as weight percen-
tage (wt%) of total fatty acids in breast milk fat – were aver-
aged for each subject, and the resulting mean values were used
for further calculations. Mean wt% of rumenic acid and other
CLA (total CLA minus rumenic acid) were computed for
groups of subjects classified by organic origin of dairy and
meat, using Student’s t test to assess differences between the
groups (not assuming equality of variances); a difference
between two groups was considered to be statistically signifi-
cant if P#0·05. A linear regression analysis used rumenic acid
level and TVA (wt%) as the dependent variables, while the
independent variables were the categories of organic or biody-
namic origin of dairy and meat and the fat intake from rumi-
nant meat and dairy (g/d). Possible interactions between origin
and fat intake were tested by adding interaction terms to
the linear regression models. Since we expected CLA levels
in fresh dairy products to be higher in summer months,
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we also included the season in which the breast milk was
sampled in the multivariate analysis, to correct for a possible
confounding effect (dichotomized into two periods: December
2002 to May 2003; June 2003 to September 2003). Other cov-
ariables in the regression analyses were: recruitment group
(conventional/alternative), maternal age, education, and the
use of oil supplements during pregnancy or lactation (yes/
no). All statistical analyses were done in SPSS version 12.0
for Windows (SPSS Inc., Chicago, IL, USA).
Results
Of the 312 participants, thirty-three (10·5 %) used 50–90 %
meat and dairy of organic origin, while thirty-seven (11·8 %)
used more than 90 % of these aliments (Table 1). The subjects
differed substantially in terms of recruitment group, and
slightly in terms of the month during which breast milk
sampling took place, education level and age of the mother,
as well as in the use of oil supplements (Table 1). Therefore,
we have included these characteristics as covariables in the
multivariate linear regression analysis. Only six (3 %) subjects
in the conventional group used any meat and dairy of biody-
namic origin, whereas, as expected, this percentage was
higher in the groups of organic users, increasing up to 30 %
use of biodynamic meat and 76 % use of biodynamic dairy
in the .90 % organic group (Table 1); the ‘other’ group had
an intermediary position. As shown in Table 1, the total fat
intake from the main dietary fat sources included in the
FFQ was comparable between the groups, but the percentage
contributed by dairy fat was almost twice as high in the
groups with 50–90 % (70 %) and .90 % (75 %) meat and
dairy of organic origin compared to the conventional group
(39 %).
The levels of rumenic acid were higher in the groups of
organic meat and dairy users, with an increasing trend going
from the ‘other’ group to the 50–90 % organic meat and
dairy group to the .90 % organic meat and dairy group
(Table 2). The difference between the levels of rumenic acid
in these groups and that in the conventional group was
always statistically significant. No such trend was found for
other CLA, and the relative amount of all the other CLA
(wt%) was slightly lower in the 50–90 % group (Table 2).
The mean level of TVA was about twice the level of rumenic
acid in breast milk and correlated with rumenic acid (r 0·51,
P,0·001). Like rumenic acid, TVA content showed an
increasing trend over the organic groups relative to the con-
ventional group (Table 2), reaching statistical significance in
the .90 % organic meat and dairy group. However, this
was not the case for the differences among the other groups,
which was probably due to the relatively high standard devi-
ation values. The most abundant fatty acids present in milk
are depicted in Table 3, to better understand the context of
the mentioned changes in CLA and TVA levels. The increases
in the levels of these fatty acids seem to be associated with
relative decreases in the levels of trans-C18 : 1 and of
C20 : 4 fatty acids.
Table 1. Relevant characteristics of the study participants†
Conventional
50–90 % organic
meat and dairy
.90 % organic
meat and dairy Other
Origin of meat and dairy products n % n % n % n %
Total number 186 100 33 100 37 100 56 100
Recruitment group
Conventional 126 68 4 12 2 5 14 25
Alternative 60 32 29 88 35 95 42 75
Maternal age (mean and SD) 32·5 3·8 34·2 3·6 35·4 4·0 33·9 3·7
Maternal education
Low 13 7 2 6 3 8 1 2
Intermediate 70 38 5 15 8 22 12 21
Higher vocational 82 44 12 36 16 43 21 38
University 21 11 14 42 10 27 22 39
Month of sampling
December to January 40 22 0 0 4 11 12 21
February to March 63 34 11 33 11 30 16 29
April to May 42 23 11 33 7 19 20 36
June to July 33 18 6 18 8 22 7 13
August to September 8 4 5 15 7 19 1 2
Oil supplement use
No 175 94 31 94 37 100 54 96
Yes 11 6 2 6 0 0 2 4
Use of biodynamic dairy
None 180 97 28 85 26 70 46 82
Any 6 3 5 15 11 30 10 18
Use of biodynamic meat
None 180 97 14 42 9 24 32 57
Any 6 3 19 58 28 76 24 43
Fat intake (g/d) from ruminant meat (mean and SD) 3·4 2·6 2·3 2·4 1·5 1·9 3·9 3·2
Fat intake (g/d) from dairy (mean and SD) 17·6 10·4 33·0 14·6 32·8 16·4 23·9 13·2
† The participants (n 312) were distributed by the various groups (conventional, 50–90 % organic, .90 % organic and other) according to the origin of the dairy and meat
products included in the corresponding diet. The characteristics of the participants attributed to each of the four groups, in terms of number, age, maternal education, month
of breast milk sampling, use of oil supplement and use of biodynamic dairy and meat products are depicted.
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After adjusting for covariables (alternative v. conventional
recruitment group; maternal age; maternal education; use of
supplements; winter v. summer months), rumenic acid
remained statistically significantly higher in the .90 %
organic group (v. conventional) (Table 4, model A). Fat
intake from ruminant meat and from dairy contributed equally
to the rumenic acid level in breast milk, but only the result for
dairy fat was statistically significant: 0·021 increment of rume-
nic acid level (as wt% of total milk fat) per 10 g/d increment
of daily dairy fat intake, P,0·001 (Table 4, model B). When
we additionally adjusted for fat intake from dairy and rumi-
nant meat, rumenic acid remained significantly higher in the
.90 % organic group compared to the conventional group
(Table 4, model C). In addition to the organic origin, dairy
fat intake still contributed to the rumenic acid level in breast
milk (Table 4, model C). In linear regression analysis of
breast milk TVA, results were very similar to those of
rumenic acid: TVA (wt% of total milk fat) was statistically
significantly higher in the .90 % organic group (v. conven-
tional, regression coefficient 0·097, SE 0·040, P¼0·015).
Moreover, TVA was dependent on dairy fat intake in a statisti-
cally significant way: 0·023 increment of TVA (as wt% of
total milk fat) per 10 g/d increment of daily dairy fat intake
(SE 0·009, P¼0·009), linear regression adjusting for the
covariables mentioned earlier. It is worth mentioning that
rumenic acid in breast milk peaked in the early summer
Table 2. Rumenic acid, other conjugated linoleic acids, trans-vaccenic acid and other relevant fatty acid classes in breast milk (as weight percentage
(wt%) of total milk fat) by origin of meat and dairy (n 312)†
(Mean values and standard deviations)
Conventional
(n 186)
. 50 % organic
meat and dairy
(n 33)
. 90 % organic
meat and dairy
(n 37) Other (n 57)
Fatty acids Mean SD Mean SD Mean SD Mean SD
Rumenic acid (cis 9,trans11-C18 : 2) 0·25 0·07 0·29* 0·10 0·34*** 0·10 0·27 0·11
Other conjugated linoleic acids 0·07 0·03 0·06* 0·03 0·07 0·03 0·07 0·03
trans-Vaccenic acid (trans11-C18 : 1) 0·48 0·21 0·54 0·26 0·59*** 0·16 0·53* 0·16
LA (C18 : 2n-6) 13·73 3·19 13·81 4·28 14·90 4·40 13·06 2·87
Sum of LA derivatives‡ 1·33 0·23 1·29 0·19 1·36 0·25 1·30 0·23
LA þ LA derivatives 15·06 3·26 15·10 4·28 16·26 4·48 14·37 2·90
a-Linolenic acid (C18 : 3n-3) 1·05 0·38 0·89* 0·41 0·82*** 0·28 0·93* 0·27
Sum of ALA derivatives§ 0·79 0·32 0·77 0·22 0·79 0·43 0·81 0·44
ALA þ ALA derivatives 1·84 0·56 1·65* 0·47 1·61* 0·61 1·74 0·48
Total PUFA 18·45 3·53 18·27 4·36 19·51 4·67 17·66 2·95
Total MUFA 40·84 3·08 39·48 4·12 38·57*** 3·20 40·28 3·97
Total SFA 40·71 4·33 42·25 5·82 41·91 5·36 42·07 4·75
ALA, a-linolenic acid; LA, linoleic acid
Mean values were significantly different from those of the conventional group (Student’s t test): *P,0·05; **P,0·01; ***P,0·001.
† For details of procedures, see pp. 736–737.
‡ Sum of LA derivatives includes: C18 : 3n-6, C20 : 3n-6, C20 : 4n-6, C22 : 4n-6 and C22 : 5n-6.
§ Sum of ALA derivatives includes : C18 : 4n-3, C20 : 4n-3, C22 : 4n-3, C22 : 5n-3 and C22 : 6n-3.
Table 3. Most abundant fatty acids in breast milk (as weight percentage (wt%) of total milk fat) by origin of meat and dairy (n 312)†
(Mean values and standard deviations)
Conventional
(n 186)
.50 % organic
meat and dairy (n 33)
.90 % organic
meat and dairy (n 37) Other (n 57)
Fatty acids Mean SD Mean SD Mean SD Mean SD
C16 : 0 22·62 2·30 22·79 2·54 22·63 2·86 23·21 2·57
C18 : 2 13·73 3·19 13·81 4·28 14·90 4·40 13·06 2·87
C18 : 0 7·02 1·48 6·60 1·49 6·87 1·15 6·95 1·66
C14 : 0 5·63 1·50 6·65** 1·74 6·42* 1·78 6·20* 1·80
C12 : 0 4·56 1·70 4·95 1·90 4·69 1·52 4·61 1·57
C18 : 3n-3 1·05 0·38 0·89* 0·41 0·82*** 0·28 0·93* 0·27
trans9-C18 : 1 0·61 0·27 0·47*** 0·20 0·51* 0·24 0·52** 0·18
C20 : 4 0·53 0·10 0·48** 0·08 0·48** 0·08 0·50* 0·09
trans11-C18 : 1 0·48 0·21 0·54 0·26 0·59*** 0·16 0·53* 0·16
C18 : 3n-6 (di-homo) 0·46 0·11 0·48 0·10 0·53** 0·13 0·47 0·12
C22 : 6 0·42 0·20 0·41 0·16 0·42 0·27 0·44 0·28
C17 : 0 0·31 0·10 0·36*** 0·07 0·34 0·12 0·33 0·11
C15 : 0 0·30 0·09 0·38*** 0·12 0·40*** 0·13 0·37*** 0·12
cis9,trans11-C18 : 2 0·25 0·07 0·29* 0·10 0·34*** 0·10 0·27 0·11
C14 : 1 0·23 0·08 0·29** 0·12 0·29* 0·12 0·29*** 0·11
Mean values were significantly different from those of the conventional group (Student’s t test): *P,0·05; **P,0·01; ***P,0·001.
† Only fatty acids present in amounts higher than 0·2 % of total milk fat are shown. For details of procedures, see pp. 736–737.
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months in the conventional and 50–90 % organic meat and
dairy users, and somewhat later in the .90 % organic group
(data not shown).
Discussion
CLA and TVA are often formed by isomerization and biohy-
drogenation of dietary linoleic and linolenic acid by microor-
ganisms (mainly Butyrovibrio fibrisolvens) living in the rumen
of ruminant animals. These reactions lead to the formation of
various positional and geometric isomers, which differ sub-
stantially in nutritional value (Banni et al. 1999). TVA is
the major trans-fatty acid in ruminant milk fat and an inter-
mediate in the bioconversion of linoleic acid (C18 : 2n-6) to
rumenic acid (cis9,trans11-C18 : 2). In man, it can be con-
verted by D9 desaturation to rumenic acid (Turpeinen et al.
2002), being probably responsible for one-quarter of the
human CLA pool (Kuhnt et al. 2006). This conversion has
been shown to occur in lactating women (Mosley et al.
2006); in this precursor study, consumed TVA was converted
in rumenic acid which was detectable in the human milk.
Other trans-fatty acids, such as trans-10-octadecenoic acid
(trans10-C18 : 1) cannot be desaturated. Bertschi et al.
(2005) have recently described an about 50 % concomitant
increase of both TVA and rumenic acid levels in human
breast milk after consumption of alpine butter, in comparison
with margarine. Since alpine butter had a high content of these
fatty acids whereas the tested margarine had hardly any
(Bertschi et al. 2005), this observation suggests that the
CLA and TVA present in human milk have a dietary origin.
At least in the Netherlands the main sources of CLA and
TVA are of dairy origin (Voorrips et al. 2002). In the present
work, however, no determination of the content in these fatty
acids in the dairy and meat products normally consumed by
the mothers of the different groups was performed.
It should be mentioned that industrially produced trans-fatty
acids, as often incorporated in commercial products, are likely
to contribute to pathological situations, such as IHD (Stender
& Dyerberg, 2004) and type 2 diabetes (Odegaard & Pereira,
2006). This possible contribution is leading several govern-
ments to limit the total amount of these fatty acids – mainly
elaidic acid (trans9-C18 : 1), but to some extent also TVA
(trans11-C18 : 1) – which can be included in oils and fats.
For instance, in the case of the Danish government, this
limit has been set to 2 % of the total fat content (Stender
et al. 2004). The oscillations of the levels of TVA reported
in the present study occur therefore within a range which is
clearly different from the one of industrially produced trans-
fatty acids, meaning that no unfavourable effects on human
health are to be expected. Furthermore, and as often occurs
in natural mixtures, the observed oscillations occur concomi-
tantly to other alterations, namely to an increase in the CLA
levels, which are likely to exert beneficial effects on health
performance.
We found that the levels of rumenic acid as well as of TVA
in breast milk were higher in mothers which included organic
dairy and meat products in their diet, in comparison with
mothers who had pursued a conventional diet. Furthermore,
the extent of the increase in rumenic acid depended on the
amount of organic products consumed during the study, with
those mothers using almost exclusively (more than 90 %)
organic dairy and meat products in their diet having a
higher content of this fatty acid in their milk than mothers
with a moderately (50–90 %) organic dairy and meat diet.
These data corroborate the results of our previous pilot
study, which showed that mothers who consumed more than
50 % organic dairy and meat products had higher levels of
CLA (Rist et al. 2003). Interestingly, it has been shown in a
variety of studies (Jahreis et al. 1997; Bergamo et al. 2003;
Gedek, 1980; Dewhurst et al. 2003) that the levels of CLA
in cow’s milk from organic producers in Europe, including
the Netherlands (Adriaansen-Tennekes et al. 2005), are sig-
nificantly higher than CLA levels in the milk from convention-
al producers. Therefore, and since the fat from human breast
milk is likely to be of dietary origin (see earlier), we believe
that the larger amounts of rumenic acid and TVA in breast
milk from the organic groups were due to the corresponding
intake of organic dairy and meat products with higher levels
of rumenic acid and TVA. This interpretation of the present
results is strengthened by the fact that the total fat intake
was comparable among the various groups and that the CLA
content of the food is very stable and not influenced by storage
or processing (Luna et al. 2005). The fat intake from meat was
five to twenty times lower than that from dairy products;
therefore, it is likely that dairy products were more strongly
influencing the final fat composition of the milk than the
Table 4. Rumenic acid in breast milk as a function of the use of either meat and dairy of organic origin (model A), or dietary
fat intake from ruminant meat and dairy products (model B) or both (model C)†
Model A Model B Model C
Parameter Coeff SE P Coeff SE P Coeff SE P
Origin of meat and dairy‡
Other 0·005 0·014 0·74 20·002 0·013 0·88
50–90 % organic 0·019 0·017 0·28 0·000 0·017 0·99
. 90 % organic 0·062 0·017 ,0·001 0·045 0·017 0·01
Fat intake from
Ruminant meat§ 0·021 0·017 0·21 0·031 0·017 0·07
Dairy§ 0·021 0·004 ,0·001 0·019 0·004 ,0·001
Coeff, linear regression coefficient; SE, standard error of the regression coefficient.
† The difference in rumenic acid (as weight percentage (wt%) of total milk fat) was assumed to vary linearly with one of the two or with both
parameters; data from the 312 participants were incorporated in the linear regression. Linear regression models controlled for the following
covariables: alternative v. conventional group; maternal age; maternal education level; use of supplements; winter v. summer months.
‡ Coefficients denote the difference in rumenic acid level (wt%) in each group compared to the conventional group.
§ Coefficients denote increase in rumenic acid level (wt%) with 10 g/d increase of fat intake.
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meat products. Much to our surprise, the multivariate analysis
found an additional effect of the organic origin on the diet,
stronger than that to be expected from the total dairy fat
intake.
The CLA levels found in the breast milk from the .90 %
organic dairy and meat products consumers were as high as
those reached after supplementation with 30 g/d alpine butter
for 10 d (Bertschi et al. 2005): 0·33 g/100 g milk fat (margar-
ine control: 0·22 g/100 g milk fat). Breast milk levels of rume-
nic acid in the conventional group (0·25 g/100 g fat) were in the
same range as the values previously reported: 0·21 g/100 g fat
(Park et al. 1999); 0·28 g/100 g total fatty acids (Ritzenthaler
et al. 2005), and 0·19 and 0·18 g/100 g fat (Jensen et al.
1998; Jensen & Lammi-Keefe, 2001). The higher levels,
namely 0·4 g/100 g fat, recorded in American (McGuire et al.
1997; Innis & King, 1999) and in German mothers (Jahreis
et al. 1999) can be attributed to a diet which normally includes
higher amounts of dairy products and/or meat. The fact that
the relative amounts of CLA and TVA correspond to less
than 1 % of the total fat should not be taken as indicative of
a reduced physiological relevance of these fatty acids. Their
mechanism of action is likely to include the production of bio-
logically active compounds and processes of intracellular sig-
nalling (Khan & Vanden Heuvel, 2003), and it is typical for
molecules participating in such processes that they are present
in very small amounts. In this context it is worth mentioning
that, although the levels of n-3 fatty acids in maternal milk
are as well rather low, they have been shown to influence
the risk of non-atopic eczema and asthma in the infant
(Oddy et al. 2006; Wijga et al. 2006). Concerning the magni-
tude of the differences in breast milk CLA levels that we
found among the various groups, it might be argued that
they are minor. Nevertheless, it should be noted that the
level in breast milk reflects CLA intake by maternal diet
and could therefore be a marker of placental supply in
uterus and possibly of ongoing supply to the child from dietary
sources of dairy products and meat shared by the family.
Taken together, these factors are likely to represent a lifelong
cumulative effect.
The health effects of CLA and TVA on human newborns
are still unknown; nevertheless there is promising evidence
stemming from animal models and from clinical studies invol-
ving human adults. Often, the positive effects of CLA on
health parameters revealed themselves stronger in animal
models than in clinical studies with man (Bhattacharya et al.
2006). One possible explanation for this discrepancy is that,
while animal studies have concentrated on very young grow-
ing rats or mice, clinical studies have exclusively focused on
adult man. This strengthens the need for long-term clinical
studies starting with very young participants, as is possible
within the frame of the KOALA study. An area in which
the expectations concerning the CLA effects are relatively
high concerns their immunomodulating properties (see
review by O’Shea et al. 2004). Indeed, in animal models,
these fatty acids lead to a reduction of the harmful effects of
intranasally administered influenza viruses, and to a reduction
of the leukotriene and prostaglandin production which
suggests a favourable effect in preventing inflammatory
phenomena that are typical of an immediate immune response
(O’Shea et al. 2004). Moreover, CLA feeding was able to pre-
vent wasting after endotoxin injections (Cook et al. 1999).
The examination of healthy human volunteers who had
been vaccinated against hepatitis B revealed that supplemen-
tation with certain CLA isomers resulted in a statistically sig-
nificant higher level of protective antibodies, indicative of a
better immune-responsiveness to the vaccination (Albers
et al. 2003). CLA supplementation in young healthy men
affected the immune function in terms of increased plasma
IgA and IgM, and the anti-inflammatory cytokine IL-10, and
decreased levels of IgE and the proinflammatory cytokines
TNF-a and IL-1g (Song et al. 2005). Dietary studies have
indicated a protective effect of butter relative to margarine
against allergy and asthma (Bolte et al. 2001; Dunder et al.
2001; Woods et al. 2003). Similarly, a 3-year prospective
cohort study found a decreased risk of asthma in children
who consumed full cream milk and butter daily, compared
to those who did not (Wijga et al. 2003). Since butter is nor-
mally rich in CLA, this might suggest a positive effect of CLA
on the prevention of those diseases. Furthermore, it is known
that children who grow up in families with an anthroposophic
lifestyle have a reduced risk of atopic diseases compared to
those in families with conventional lifestyles (Alm et al.
1999; Alfven et al. 2006). An anthroposophic lifestyle com-
prises, besides a restrictive use of antibiotics and few vacci-
nations, a diet that usually contains raw milk and organic, or
more specifically biodynamic, products. Given that an organic
diet and organic dairy and/or meat products have a higher
CLA content than their conventional counterparts (see earlier),
this observation might suggest that CLA consumption could
add to a protective effect against atopic diseases.
In conclusion, we show here that the levels of both rumenic
acid and TVA in human breast milk were higher in the case of
mothers following a diet that contained organic dairy and
meat products, in comparison with mothers consuming a con-
ventional diet. In view of the accumulating evidence pointing
towards various positive effects of CLA on human health, in
particular at a very young age, the present results are
highly interesting. Further results of the KOALA Birth Cohort
Study, in particular those concerning allergic sensitization and
asthma in the children corresponding to the mothers that have
participated in the present study, are awaited anxiously.
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